The immune system relies upon a diverse repertoire of B and T cells to ward off disease. With billions of cells, our adaptive immune system is a formidable opponent to everything from colds, to cancer to cartons of old milk.
Augmenta’s technology finds the needle in the haystack – that one cell, out of billions of cells, out of billions of people, that holds the cure. With the power of modern molecular biology, that winning lottery ticket can be spread and shared by everyone.
We utilize advanced automation, microfluidics, high throughput DNA sequencing, and massively scalable computational analysis to identify immune receptors and their antigen specificity. We provide scientists an unprecedented view of the immune system to guide development of new therapeutics.